Records containing: Skin Toxicity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-27Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
-
CLINICAL_TRIALS study record update · 2025-08-08The PROTECT Study: A Phase II, Open-Label Trial of PROphylactic Skin Toxicity ThErapy With Clindamycin and Triamcinolone in Glioblastoma Patients Treated With Tumor Treating Fields
-
CLINICAL_TRIALS study record update · 2025-05-06Observational Study on Skin Toxicity by Oncological Therapies
-
CLINICAL_TRIALS study record update · 2023-11-07Efficacy and Safety of Crisaborole Ointment, a Phosphodiesterase 4 (PDE4) Inhibitor, for the Topical Treatment of Cetuximab-Related Skin Toxicity Among Metastatic Colorectal Cancer Patients：A Prospective, Single-arm, Phase II Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-03-01Evaluation of a Novel Skin Care Product for the Management of Chemotherapy- Related Dermatologic Toxicities
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-02-28Evaluation of Novel Skin Care Products for the Management of Immunotherapy- Related Dermatologic Toxicities
-
CLINICAL_TRIALS study record update · 2021-09-09Double-blind, Phase II Study to Assess the Effectiveness of Lycopene vs Placebo to Reduce Skin Toxicity in Patients With Colorectal Carcinoma Treated With Panitumumab
-
CLINICAL_TRIALS study record update · 2020-04-08Phase II Clinical Trial of Doxycycline 50 mg or 100 mg Daily for the Prevention of Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy
-
CLINICAL_TRIALS study record update · 2020-03-25Pre-emptive Cycline Treatment on Cetuximab-induced Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With an Intensified FOLFIRI.
-
CLINICAL_TRIALS study record update · 2018-07-31Evaluation of Topical Corticosteroids Potency in Combination Preparations in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2016-08-03Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27
-
CLINICAL_TRIALS study record update · 2010-08-10Selected Skin Products for Cancer Patients: A Product Satisfaction Survey